Due Diligence Support (Buy-Side): Fund Manager
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Buy-Side Due Diligence Support for Life Sciences Investment Fund Manager
Portfolio Valuation: Life Sciences Investments
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Pension Plan Needs Life Sciences Investment Portfolio Valuation
M&A Valuation Support: Medical Device Company
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Venture-backed Medical Device Company Needs to Assess Value From Different Perspectives
Doug Hughes, Neotrack
“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”
Go-to-Market Pricing & Clinical Workflows: Cardiac Medical Device
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Go-To-Market Pricing Study and Clinical Workflow Assessment
Corporate Strategy: Growth Options for Medtech in Heart Failure
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Comprehensive Assessment of Growth Options and a Plan for a Strategic Pivot
Buy-Side Due Diligence: Organ on a Chip
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Buy-side Due Diligence Support for a Potential Investor